All Resources
App Note
Abveris on Antibody Discovery

Discover how Abveris transformed its antibody discovery processes with the Beacon® optofluidic system.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Meet Colby A. Souders, PhD, Chief Scientific Officer at Abveris.
Explore Abveris's strategy to reduce timelines and discover antibodies against difficult targets.
Learn how easy it is to select the best lead antibody candidates on the Beacon system.
Get the App Note